Evidence of graft-versus-tumor effect in refractory metastatic neuroblastoma.
Hirayama
Masahiro
M
Azuma
Eiichi
E
Araki
Mariko
M
Komada
Yoshihiro
Y
Nakagawa
Atsuko
A
D015703:Antigens, CD / Q000032:analysis; D001854:Bone Marrow Cells / Q000276:immunology; D002648:Child; D016572:Cyclosporine / Q000008:administration & dosage; D005260:Female; D020350:Graft vs Tumor Effect; D006719:Homovanillic Acid / Q000652:urine; D006801:Humans; D009447:Neuroblastoma / Q000556:secondary / Q000628:therapy*; D018242:Neuroectodermal Tumors, Primitive / Q000473:pathology / Q000628:therapy*; D014446:Tyrosine 3-Monooxygenase / Q000032:analysis / Q000276:immunology; D014642:Vanilmandelic Acid / Q000652:urine
D015703:Antigens, CD; D014642:Vanilmandelic Acid; D016572:Cyclosporine; D014446:Tyrosine 3-Monooxygenase; D006719:Homovanillic Acid